Novocure Ltd (NVCR)
$13.15 +0.31% Close Oct 30, 2026 Live
Novocure stock today
Novocure closed at $13.15 on October 30, 2026, up 0.31% on the day. Over the past year it returned +2.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.53 billion.
$10.00$15.00$20.00
NovJan 2026MarMayJulSep
| Period | NVCR | S&P 500 (SPY) |
|---|---|---|
| 1 month | -17.6% | -0.9% |
| 3 months | -13.7% | +2.1% |
| Year to date | +1.7% | +11.7% |
| 1 year | +2.6% | +12.4% |
| 3 years | +0.7% | +88.5% |
| 5 years | -87.2% | +76.0% |
Key statistics
- Market value
- $1.53B
- Price / sales
- 2.1
- 52-week range
- $10.03 to $19.99
About Novocure
Develops tumor-treating electric field therapy for solid tumors.
Sector: Health Care
More on Novocure
- Financials: revenue, earnings and segmentsRevenue +8% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $2,149 today
No forecast, no recommendation. This page describes Novocure Ltd from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.